The Therapeutic Effect of Traditional Chinese Medicine on Inflammatory Diseases Caused by Virus, Especially on Those Caused by COVID-19.

Abstract

Inflammasomes are large multimolecular complexes best recognized because of their ability to control activation of caspase-1, which in turn regulates the maturation of interleukin-18 (IL-18) and interleukin-1 β (IL-1β). IL-1β was originally identified as a pro-inflammatory cytokine, capable of inducing local and systemic inflammation as well as a fever response reaction in response to infection or injury. Excessive production of IL-1β is related to inflammatory and autoimmune diseases. Both coronavirus disease 2019 (COVID-19) and severe acute respiratory syndrome (SARS) are characterized by excessive inflammatory response. For SARS, there is no correlation between viral load and worsening symptoms. However, there is no specific medicine which is available to treat the disease. As an important part of medical practice, TCM showed an obvious therapeutic effect in SARS-CoV-infected patients. In this article, we summarize the current applications of TCM in the treatment of COVID-19 patients. Herein, we also offer an insight into the underlying mechanisms of the therapeutic effects of TCM, as well as introduce new naturally occurring compounds with anti-coronavirus activity, in order to provide a new and potential drug development strategy for the treatment of COVID-19.

• Authors: Peng Li, Shuang Hu, Cheng Qian, Yan Yao, Liang-Yun Li, Jun-Fa Yang, Li Yang, Chen-Chen Yang, Hong Zhou, Shu-Xian Wang, Ying Hu, Xing-Yu Zhu, Jing Zhou, Lin-Xin Pan, Chuan-Pu Shen, Huan Zhou
• Journal: Frontiers in pharmacology (Front Pharmacol) Vol. 12 Pg. 650425 ( 2021) ISSN: 1663-9812 [Print] Switzerland
• PMID: 34122073 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2021 Li, Hu, Qian, Yao, Li, Yang, Yang, Yang, Zhou, Wang, Hu, Zhu, Zhou, Pan, Shen and Zhou.